Safety of pembrolizumab in combination with bevacizumab in recurrent glioblastoma (rGBM).
Publication
, Conference
Reardon, DA; De Groot, JF; Colman, H; Jordan, JT; Daras, M; Clarke, JL; Nghiemphu, PL; Gaffey, SC; Peters, KB
Published in: Journal of Clinical Oncology
May 20, 2016
Duke Scholars
Published In
Journal of Clinical Oncology
DOI
EISSN
1527-7755
ISSN
0732-183X
Publication Date
May 20, 2016
Volume
34
Issue
15_suppl
Start / End Page
2010 / 2010
Publisher
American Society of Clinical Oncology (ASCO)
Related Subject Headings
- Oncology & Carcinogenesis
- 3211 Oncology and carcinogenesis
- 1112 Oncology and Carcinogenesis
- 1103 Clinical Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Reardon, D. A., De Groot, J. F., Colman, H., Jordan, J. T., Daras, M., Clarke, J. L., … Peters, K. B. (2016). Safety of pembrolizumab in combination with bevacizumab in recurrent glioblastoma (rGBM). In Journal of Clinical Oncology (Vol. 34, pp. 2010–2010). American Society of Clinical Oncology (ASCO). https://doi.org/10.1200/jco.2016.34.15_suppl.2010
Reardon, David A., John Frederick De Groot, Howard Colman, Justin T. Jordan, Mariza Daras, Jennifer Leigh Clarke, Phioanh Leia Nghiemphu, Sarah C. Gaffey, and Katherine B. Peters. “Safety of pembrolizumab in combination with bevacizumab in recurrent glioblastoma (rGBM).” In Journal of Clinical Oncology, 34:2010–2010. American Society of Clinical Oncology (ASCO), 2016. https://doi.org/10.1200/jco.2016.34.15_suppl.2010.
Reardon DA, De Groot JF, Colman H, Jordan JT, Daras M, Clarke JL, et al. Safety of pembrolizumab in combination with bevacizumab in recurrent glioblastoma (rGBM). In: Journal of Clinical Oncology. American Society of Clinical Oncology (ASCO); 2016. p. 2010–2010.
Reardon, David A., et al. “Safety of pembrolizumab in combination with bevacizumab in recurrent glioblastoma (rGBM).” Journal of Clinical Oncology, vol. 34, no. 15_suppl, American Society of Clinical Oncology (ASCO), 2016, pp. 2010–2010. Crossref, doi:10.1200/jco.2016.34.15_suppl.2010.
Reardon DA, De Groot JF, Colman H, Jordan JT, Daras M, Clarke JL, Nghiemphu PL, Gaffey SC, Peters KB. Safety of pembrolizumab in combination with bevacizumab in recurrent glioblastoma (rGBM). Journal of Clinical Oncology. American Society of Clinical Oncology (ASCO); 2016. p. 2010–2010.
Published In
Journal of Clinical Oncology
DOI
EISSN
1527-7755
ISSN
0732-183X
Publication Date
May 20, 2016
Volume
34
Issue
15_suppl
Start / End Page
2010 / 2010
Publisher
American Society of Clinical Oncology (ASCO)
Related Subject Headings
- Oncology & Carcinogenesis
- 3211 Oncology and carcinogenesis
- 1112 Oncology and Carcinogenesis
- 1103 Clinical Sciences